Literature DB >> 214230

Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas.

C W van Veelen, H Verbiest, A M Vlug, G Rijksen, G E Staal.   

Abstract

Pyruvate kinase isozymes were studied in normal brain tissue (both fetal and adult) and in meningiomas and malignant gliomas. In fetal brain five different forms could be detected by electrophoresis (K4, K3M, K2M2, KM3, and M4). In adult brain the M4-type, K3M hybrid, and K4-type are present; the M isozyme is largely predominant. Alanine inhibition of pyruvate kinase is in agreement with the electrophoretic pattern. Pyruvate kinase from fetal brain and brain of a newborn is more inhibited compared with pyruvate kinase from adult brain. The Lineweaver-Burk plots for pyruvate kinase from fetal brain and brain of the newborn are nonlinear due to the presence of hybrids. Pyruvate kinase from meningiomas and malignant gliomas is strongly inhibited by alanine. Electrophoresis proved the presence of mainly K4 type and the hybrid K3M, which is in agreement with the alanine inhibition. Determination of the Km's for phosphoenolpyruvate supports this conclusion. The determination of the alanine inhibition of pyruvate kinase may be a diagnostic tool in surgery for gliomas.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214230

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

Authors:  Xueliang Gao; Haizhen Wang; Jenny J Yang; Xiaowei Liu; Zhi-Ren Liu
Journal:  Mol Cell       Date:  2012-02-02       Impact factor: 17.970

2.  Immunohistochemical localization of pyruvate kinase isoenzymes in chicken tissues.

Authors:  M Reinacher; E Eigenbrodt; B Schering; W Schoner
Journal:  Histochemistry       Date:  1979-11

3.  Pyruvate kinase in human brain tumours. Its significance in the treatment of gliomas.

Authors:  C W van Veelen; H Verbiest; K J Zülch; B van Ketel; M J van der Vlist; A M Vlug; G Rijksen; G E Staal
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

4.  Pyruvate kinase inhibition in the diagnosis of gliomas with an intermediate degree of malignancy.

Authors:  H W Mostert; N J de Both; E H Rhijnsburger; W M Mackay; J H van den Berge; S Z Stefanko
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 5.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

6.  Discrimination between neuronal and glial cell tumours by pyruvate kinase electrophoresis.

Authors:  C W van Veelen; G Rijksen; G E Staal
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 7.  Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.

Authors:  Tiago M A Carvalho; Daria Di Molfetta; Maria Raffaella Greco; Tomas Koltai; Khalid O Alfarouk; Stephan J Reshkin; Rosa A Cardone
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

8.  Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.

Authors:  Mani Shankar Babu; Sailendra Mahanta; Alexander J Lakhter; Takashi Hato; Subhankar Paul; Samisubbu R Naidu
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.